Concept information
...
main group molecular entity
p-block molecular entity
carbon group molecular entity
organic molecular entity
...
glycolipid
glycosphingolipid
neolacto-series glycosphingolipid
n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide
...
glycolipid
glycosphingolipid
neolacto-series glycosphingolipid
n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide
...
sphingolipid
glycosphingolipid
neolacto-series glycosphingolipid
n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide
...
sphingolipid
glycosphingolipid
neolacto-series glycosphingolipid
n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide
...
sphingolipid
glycosphingolipid
neolacto-series glycosphingolipid
n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide
...
ceramide
oligoglycosylceramide
glycododecaosylceramide
n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide
...
ceramide
oligoglycosylceramide
glycododecaosylceramide
n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide
...
ceramide
oligoglycosylceramide
glycododecaosylceramide
n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide
...
ceramide
oligoglycosylceramide
glycododecaosylceramide
n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide
...
ceramide
oligoglycosylceramide
glycododecaosylceramide
n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide
...
ceramide
oligoglycosylceramide
glycododecaosylceramide
n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide
...
neutral glycosphingolipid
oligoglycosylceramide
glycododecaosylceramide
n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide
...
neutral glycosphingolipid
oligoglycosylceramide
glycododecaosylceramide
n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide
...
neutral glycosphingolipid
oligoglycosylceramide
glycododecaosylceramide
n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide
...
neutral glycosphingolipid
oligoglycosylceramide
glycododecaosylceramide
n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide
...
neutral glycosphingolipid
oligoglycosylceramide
glycododecaosylceramide
n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide
اصطلاح مرجح
n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide(d18:0)
نوع
-
http://www.irandoc.ac.ir/onto/irandoc-meta/Concept
مفهوم اعم
- n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-[n-acetyl-alpha-d-galactosaminyl-(1->3)-(alpha-l-fucosyl-(1->2))-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->6)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide
- organic molecular entity
بار
- 0
فرمول
- C101H173N6O61R
جرم
- 2447.462
جرم تکایزوتوپی
- 2446.06197
اسمایلٓ
- O[C@@H]1[C@H]([C@@H](O[C@@H]([C@H]1O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O[C@@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)NC(=O)C)O[C@H]4[C@H]([C@@H]([C@@H]([C@@H](O4)C)O)O)O)CO)O[C@@H]5[C@H]([C@@H](O[C@@H]([C@@H]5O)CO[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O[C@H]7[C@@H]([C@H]([C@H]([C@H](O7)CO)O)O[C@@H]8[C@@H]([C@H]([C@H]([C@H](O8)CO)O)O)NC(=O)C)O[C@H]9[C@H]([C@@H]([C@@H]([C@@H](O9)C)O)O)O)O)NC(=O)C)O[C@H]%10[C@@H]([C@H]([C@@H](O[C@@H]%10CO)O[C@@H]%11[C@H]([C@@H](O[C@@H]([C@@H]%11O)CO)O[C@H]%12[C@@H]([C@H]([C@@H](O[C@@H]%12CO)OC[C@@H]([C@@H](CCCCCCCCCCCCCCC)O)NC(=O)*)O)O)O)NC(=O)C)O)O)NC(=O)C
زیرمجموعه
- 2_STAR
مترادف مرتبط
- alpha-D-GalNAc-(1->3)-[alpha-L-Fuc-(1->2)]-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-[alpha-D-GalNAc-(1->3)-(alpha-L-Fuc-(1->2))-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)]-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:0)
- a neolactoside IV(6),IV(3)-beta-[GalNAc-alpha-(1->3)-(Fuc-alpha-(1->2))-Gal-beta-(1->4)-GlcNAc]2-nLc4Cer(d18:0)
- blood group type II chain isoA(c) (d18:0)
- N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[N-acetyl-alpha-D-galactosaminyl-(1->3)-(alpha-L-fucosyl-(1->2))-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphinganine(d18:0)
URI
http://www.irandoc.acir/onto/irandoc/CHEBI:144493
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}

